Armata Pharmaceuticals

About:

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

Website: https://www.armatapharma.com/

Top Investors: Innoviva, Cystic Fibrosis Foundation, Medical Technology Enterprise Consortium, Corvesta, Inc, Renaissance Holding Company

Description:

Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. Antibiotic overuse has led to the marked rise of multidrug-resistant bacteria, putting us on the verge of a post-antibiotic era in which common infections can be serious or life-threatening. Additionally, the use of broad-spectrum antibiotics is known for disrupting the ecology of the human microbiome, leading to disease. The company was founded in 2005 and is based in Marina del Rey, CA, USA.